Prostate cancer gene therapy

Past experiences and future promise

Thomas Gardner, James Sloan, Sudhanshu P. Raikwar, Chinghai Kao

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Gene therapy has been used to target prostate cancer with excellent pre-clinical efficacy but limited clinical efficacy. The concept of delivering genetic material to prostate cancer cells to alter their phenotype and ultimately their behavior has been demonstrated in the laboratory over the last decade. Translating those pre-clinical findings into novel therapies for prostate cancer has been difficult. The stigma of gene therapy and the aggressive regulation of clinical trials involving transfer of genetic material to patients are two major impediments to clinical successes in gene therapy. This review hopes to provide a snapshot of prior gene transfer protocol findings and forecast the exciting future directions investigators are heading.

Original languageEnglish (US)
Pages (from-to)137-145
Number of pages9
JournalCancer and Metastasis Reviews
Volume21
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Neoplasm Genes
Genetic Therapy
Prostatic Neoplasms
Genes
Research Personnel
Clinical Trials
Phenotype
Therapeutics

Keywords

  • Gene therapy
  • Metastatic
  • Prostate cancer trials
  • Transcriptional targeting
  • Tumor-specific promoters

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Prostate cancer gene therapy : Past experiences and future promise. / Gardner, Thomas; Sloan, James; Raikwar, Sudhanshu P.; Kao, Chinghai.

In: Cancer and Metastasis Reviews, Vol. 21, No. 2, 2002, p. 137-145.

Research output: Contribution to journalArticle

Gardner, Thomas ; Sloan, James ; Raikwar, Sudhanshu P. ; Kao, Chinghai. / Prostate cancer gene therapy : Past experiences and future promise. In: Cancer and Metastasis Reviews. 2002 ; Vol. 21, No. 2. pp. 137-145.
@article{b313eea4a46f4b0dbfd2214fea730462,
title = "Prostate cancer gene therapy: Past experiences and future promise",
abstract = "Gene therapy has been used to target prostate cancer with excellent pre-clinical efficacy but limited clinical efficacy. The concept of delivering genetic material to prostate cancer cells to alter their phenotype and ultimately their behavior has been demonstrated in the laboratory over the last decade. Translating those pre-clinical findings into novel therapies for prostate cancer has been difficult. The stigma of gene therapy and the aggressive regulation of clinical trials involving transfer of genetic material to patients are two major impediments to clinical successes in gene therapy. This review hopes to provide a snapshot of prior gene transfer protocol findings and forecast the exciting future directions investigators are heading.",
keywords = "Gene therapy, Metastatic, Prostate cancer trials, Transcriptional targeting, Tumor-specific promoters",
author = "Thomas Gardner and James Sloan and Raikwar, {Sudhanshu P.} and Chinghai Kao",
year = "2002",
doi = "10.1023/A:1020875925685",
language = "English (US)",
volume = "21",
pages = "137--145",
journal = "Cancer and Metastasis Reviews",
issn = "0167-7659",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Prostate cancer gene therapy

T2 - Past experiences and future promise

AU - Gardner, Thomas

AU - Sloan, James

AU - Raikwar, Sudhanshu P.

AU - Kao, Chinghai

PY - 2002

Y1 - 2002

N2 - Gene therapy has been used to target prostate cancer with excellent pre-clinical efficacy but limited clinical efficacy. The concept of delivering genetic material to prostate cancer cells to alter their phenotype and ultimately their behavior has been demonstrated in the laboratory over the last decade. Translating those pre-clinical findings into novel therapies for prostate cancer has been difficult. The stigma of gene therapy and the aggressive regulation of clinical trials involving transfer of genetic material to patients are two major impediments to clinical successes in gene therapy. This review hopes to provide a snapshot of prior gene transfer protocol findings and forecast the exciting future directions investigators are heading.

AB - Gene therapy has been used to target prostate cancer with excellent pre-clinical efficacy but limited clinical efficacy. The concept of delivering genetic material to prostate cancer cells to alter their phenotype and ultimately their behavior has been demonstrated in the laboratory over the last decade. Translating those pre-clinical findings into novel therapies for prostate cancer has been difficult. The stigma of gene therapy and the aggressive regulation of clinical trials involving transfer of genetic material to patients are two major impediments to clinical successes in gene therapy. This review hopes to provide a snapshot of prior gene transfer protocol findings and forecast the exciting future directions investigators are heading.

KW - Gene therapy

KW - Metastatic

KW - Prostate cancer trials

KW - Transcriptional targeting

KW - Tumor-specific promoters

UR - http://www.scopus.com/inward/record.url?scp=0036432858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036432858&partnerID=8YFLogxK

U2 - 10.1023/A:1020875925685

DO - 10.1023/A:1020875925685

M3 - Article

VL - 21

SP - 137

EP - 145

JO - Cancer and Metastasis Reviews

JF - Cancer and Metastasis Reviews

SN - 0167-7659

IS - 2

ER -